triazoles has been researched along with Clerambault Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andreu, F; Guitart, X; Ovalle, S; Pérez, MP; Zamanillo, D | 1 |
| Ban, TA; Clarke, R; Hontela, S; Nair, NP | 1 |
| Amin, M; Ban, TA; Bronheim, LA; Galvan, L; Klingner, A; Lehmann, HE; Nair, NP; Vergara, L; Zoch, C | 1 |
2 trial(s) available for triazoles and Clerambault Syndrome
| Article | Year |
|---|---|
Trazodone in the treatment of organic brain syndromes, with special reference to psychogeriatrics.
Topics: Aged; Antidepressive Agents; Clinical Trials as Topic; Dementia; Female; Humans; Male; Neurocognitive Disorders; Piperazines; Placebos; Psychiatric Status Rating Scales; Pyridines; Time Factors; Triazoles | 1973 |
Differential effects of trazodone in depressed, schizophrenic and geriatric patients.
Topics: Adult; Antidepressive Agents; Clinical Trials as Topic; Dementia; Depression; Female; Humans; Male; Middle Aged; Neurocognitive Disorders; Piperazines; Psychiatric Status Rating Scales; Pyridines; Schizophrenia; Time Factors; Triazoles | 1974 |
1 other study(ies) available for triazoles and Clerambault Syndrome
| Article | Year |
|---|---|
Effect of the novel sigma1 receptor ligand and putative atypical antipsychotic E-5842 on BDNF mRNA expression in the rat brain.
Topics: Animals; Antipsychotic Agents; Brain; Brain-Derived Neurotrophic Factor; Down-Regulation; Frontal Lobe; Hippocampus; Male; Neostriatum; Nerve Growth Factor; Neurocognitive Disorders; Neurons; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, sigma; RNA, Messenger; Sigma-1 Receptor; Synaptic Transmission; Triazoles | 2002 |